Corbus Pharma's Q2 Net Loss Widens
(RTTNews) - Corbus Pharmaceuticals Holdings, Inc. (CRBP), a U.S.-based pharmaceutical company, reported a wider loss in the second quarter.
The company reported a net loss of $17.7 million or $1.44 per share in the second quarter of 2025, compared to a net loss of $10 million or $0.90 per share.
The rise in losses during this quarter was caused by increased operating expenses, particularly driven by higher clinical development expenses.
Tuesday, CRBP closed at $8.90, down 4.71%, and is trading flat after hours on the NasdaqCM.
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.